These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1512250

  • 1. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution.
    Reilly CF, Hutzelmann JE.
    J Biol Chem; 1992 Aug 25; 267(24):17128-35. PubMed ID: 1512250
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF, Fujita T, Hutzelmann JE, Mayer EJ, Shebuski RJ.
    Circulation; 1991 Jul 25; 84(1):287-92. PubMed ID: 1905594
    [Abstract] [Full Text] [Related]

  • 3. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA, Owensby DA, Sobel BE, Schwartz AL.
    J Biol Chem; 1989 May 05; 264(13):7228-35. PubMed ID: 2540181
    [Abstract] [Full Text] [Related]

  • 4. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 05; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.
    Reilly CF, Fujita T, Mayer EJ, Siegfried ME.
    Arterioscler Thromb; 1991 Aug 05; 11(5):1276-86. PubMed ID: 1911713
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The activation of plasminogen by T-PA-PAI-1 complex in the absence of fibrin.
    Takada Y, Takada A.
    Thromb Res; 1991 Jul 01; 63(1):169-77. PubMed ID: 1835180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
    Bu G, Morton PA, Schwartz AL.
    J Biol Chem; 1992 Aug 05; 267(22):15595-602. PubMed ID: 1322401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C, Young GD, Barr CF, Colleton CA, Alving BM.
    J Lab Clin Med; 1991 Dec 05; 118(6):523-30. PubMed ID: 1744501
    [Abstract] [Full Text] [Related]

  • 17. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 05; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W.
    Blood; 1990 Dec 01; 76(11):2284-9. PubMed ID: 1701665
    [Abstract] [Full Text] [Related]

  • 20. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
    Gaussem P, Anglés-Cano E.
    Biochim Biophys Acta; 1991 Sep 20; 1079(3):321-9. PubMed ID: 1911857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.